Associated Papers
Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation.
Corsetti JP et al.
Atherosclerosis, 2016
Select a paper to view details